Filing Details

Accession Number:
0001415889-23-016965
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-27 18:30:08
Reporting Period:
2023-12-26
Accepted Time:
2023-12-27 18:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD Surgical & Medical Instruments & Apparatus (3841) 731408526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1613801 E. Roger Susi C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708
Ceo, President, Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-26 5,000 $46.00 167,950 No 4 S Indirect By Roger E. Susi Revocable Trust
Common Stock Disposition 2023-12-27 5,000 $46.51 162,950 No 4 S Indirect By Roger E. Susi Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Roger E. Susi Revocable Trust
No 4 S Indirect By Roger E. Susi Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,062,500 Indirect By Matthew Susi 2008 Dynasty Trust
Common Stock 2,362,500 Indirect By Phillip Susi 2008 Dynasty Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $46.50 to $46.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.